表紙
市場調查報告書
商品編碼
1028947

癌症免疫治療藥的全球市場:COVID-19的成長及變化預測 (∼2030年)

Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球癌症免疫治療藥的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的轉變·預測,類型·治療用途·終端用戶·地區/主要國家等各種區分的明細,競爭環境,主要企業的簡介,未來展望等資料。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場趨勢·市場策略

第4章 COVID-19的影響

第5章 市場規模·成長預測

  • 市場規模的轉變·預測
  • 市場成長的促進因素
  • 市場阻礙成長要素

第6章 市場分析·預測:各種區分

  • 各類型
    • 單株抗體
    • 免疫查核點抑制劑
    • 免疫系統調製器
    • 癌症疫苗
    • 其他
  • 各治療用途
    • 黑色素瘤
    • 肺癌
    • 血液癌症
    • 腎細胞癌
    • 前列腺癌
    • 膀胱癌
    • 其他
  • 各終端用戶
    • 醫院
    • 診所
    • 門診病人手術中心
    • 癌症研究機關

第7章 市場分析·預測:各地各國

第8章 亞太地區市場分析·預測

  • 市場概要
  • 地區資訊·COVID-19的影響·市場資訊·背景資訊·政府措施·法律規章·機關&協會·租稅·投資·主要企業
  • 市場分析·預測:各類型
  • 市場分析·預測:各治療用途

第9章 中國市場分析·預測

第10章 印度市場分析·預測

第11章 日本市場分析·預測

第12章 澳洲市場分析·預測

第13章 印尼市場分析·預測

第14章 韓國市場分析·預測

第15章 西歐市場分析·預測

第16章 英國市場分析·預測

第17章 德國市場分析·預測

第18章 法國市場分析·預測

第19章 東歐市場分析·預測

第20章 俄羅斯市場分析·預測

第21章 北美市場分析·預測

第22章 美國市場分析·預測

第23章 南美市場分析·預測

第24章 巴西市場分析·預測

第25章 中東市場分析·預測

第26章 非洲市場分析·預測

第27章 競爭情形·企業簡介

  • 競爭情形
  • 企業簡介
    • Amgen, Inc.
    • AstraZeneca Plc
    • Bristol-Myers Squibb
    • Celgene Corporation
    • Eli Lilly and Company

第28章 開發平台分析

第28章 主要M&A

第29章 未來展望·潛在性分析

第30章 附錄

目錄
Product Code: h972

Immuno-Oncology Drugs Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global immuno-oncology drugs market.

This report focuses on immuno-oncology drugs market which is experiencing strong growth. The report gives a guide to the immuno-oncology drugs market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the immuno-oncology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Immuno-Oncology Drugs market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider immuno-oncology drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The immuno-oncology drugs market section of the report gives context. It compares the immuno-oncology drugs market with other segments of the immuno-oncology drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, immuno-oncology drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Monoclonal Antibodies; Immune Checkpoint Inhibitors; Immune System Modulators; Cancer Vaccines; Others

2) By Therapeutic Application: Melanoma; Lung Cancer; Blood Cancer; Renal Cell Carcinoma; Prostate Cancer; Bladder Cancer; Others

3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Cancer Research Institutes

Companies Mentioned: Amgen, Inc.; AstraZeneca Plc; Bristol-Myers Squibb; Celgene Corporation; Eli Lilly and Company

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Immuno-Oncology Drugs Market Characteristics

3. Immuno-Oncology Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Immuno-Oncology Drugs

5. Immuno-Oncology Drugs Market Size And Growth

  • 5.1. Global Immuno-Oncology Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Immuno-Oncology Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Immuno-Oncology Drugs Market Segmentation

  • 6.1. Global Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal Antibodies
  • Immune Checkpoint Inhibitors
  • Immune System Modulators
  • Cancer Vaccines
  • Others
  • 6.2. Global Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Melanoma
  • Lung Cancer
  • Blood Cancer
  • Renal Cell Carcinoma
  • Prostate Cancer
  • Bladder Cancer
  • Others
  • 6.3. Global Immuno-Oncology Drugs Market, Segmentation By End-user, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

7. Immuno-Oncology Drugs Market Regional And Country Analysis

  • 7.1. Global Immuno-Oncology Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Immuno-Oncology Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Immuno-Oncology Drugs Market

  • 8.1. Asia-Pacific Immuno-Oncology Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Immuno-Oncology Drugs Market

  • 9.1. China Immuno-Oncology Drugs Market Overview
  • 9.2. China Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Immuno-Oncology Drugs Market

  • 10.1. India Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Immuno-Oncology Drugs Market

  • 11.1. Japan Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Immuno-Oncology Drugs Market

  • 12.1. Australia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Immuno-Oncology Drugs Market

  • 13.1. Indonesia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Immuno-Oncology Drugs Market

  • 14.1. South Korea Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Immuno-Oncology Drugs Market

  • 15.1. Western Europe Immuno-Oncology Drugs Market Overview
  • 15.2. Western Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Immuno-Oncology Drugs Market

  • 16.1. UK Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Immuno-Oncology Drugs Market

  • 17.1. Germany Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Immuno-Oncology Drugs Market

  • 18.4. France Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Immuno-Oncology Drugs Market

  • 19.1. Eastern Europe Immuno-Oncology Drugs Market Overview
  • 19.2. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Immuno-Oncology Drugs Market

  • 20.1. Russia Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Immuno-Oncology Drugs Market

  • 21.1. North America Immuno-Oncology Drugs Market Overview
  • 21.2. North America Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Immuno-Oncology Drugs Market

  • 22.1. USA Immuno-Oncology Drugs Market Overview
  • 22.2. USA Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Immuno-Oncology Drugs Market

  • 23.1. South America Immuno-Oncology Drugs Market Overview
  • 23.2. South America Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Immuno-Oncology Drugs Market

  • 24.1. Brazil Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Immuno-Oncology Drugs Market

  • 25.1. Middle East Immuno-Oncology Drugs Market Overview
  • 25.2. Middle East Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Immuno-Oncology Drugs Market

  • 26.1. Africa Immuno-Oncology Drugs Market Overview
  • 26.2. Africa Immuno-Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Immuno-Oncology Drugs Market, Segmentation By Therapeutic Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Immuno-Oncology Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Immuno-Oncology Drugs Market Competitive Landscape
  • 27.2. Immuno-Oncology Drugs Market Company Profiles
    • 27.2.1. Amgen, Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. AstraZeneca Plc
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Bristol-Myers Squibb
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Celgene Corporation
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Eli Lilly and Company
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Immuno-Oncology Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The Immuno-Oncology Drugs Market

30. Immuno-Oncology Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer